Tranzyme, Inc. (TZYM) Posts Q3 Loss of $0.26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall St set for lower open as hot inflation data fuels rate-hike bets
- Oil prices surge as Iran deploys new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts TZYM Hot Sheet
Join SI Premium – FREE
Tranzyme, Inc. (NASDAQ: TZYM) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $2.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- State Street (STT) Tops Q3 EPS by 2c
- Solitron Devices, Inc. (SODI) Tops Q2 EPS by 60c
- AZZ, Inc. (AZZ) Tops Q2 EPS by 15c; raises guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
